Astex Pharmaceuticals, Inc. Message Board
-
sTRANGE
And not good the stock is drifting down this AM on relatively heavy volume a day or two before the Dacogen final decisiion from the EU. Should be the reverse
-
Seen plenty of weirdness and questionable trading and share price manipulation in the biotech universe. Those looking for instant gratification may be disappointed if share price does not do an instant blast off. Even with fda approval the short side can suppress share price until they are ready to take their foot off. Astx goes higher with ema and it's not if but when. All IMHO.
- 1 Reply to toowan12
-
I think that the reality of PPHM a .58 stock on July 2nd that rose to a high of $5.50 on 9/21/12 and sank today (9/24) to a low as .80 has shell shocked the small bio community.
-
Happy now Bat? Wish the volume was a bit higher....
Sentiment: Strong Buy
- 1 Reply to maximus06906
-
happier than 945 this morning
-
It is the fallout from the MP470 news, which is being republished in multiple places, investor sites, blogs, bio-newsletters. Google sends me emails with info on ASTX and the news release has been cited or republished in at least 10 places now.
In an age of amazing access to information, NOT ONE of the articles I saw mentioning the MP 470 stoppage mentioned the HUGE catalyst of the EU AML decision being less than a week away. None said, "hey, if you sell on this news you may miss the boat next week."
By the way, if the share price was tanking today on heavy volume, I would say it may reflect insider info sales and the EU decision. I'm not seeing that.
M- 1 Reply to eastcountybamboo
-
I believe criminal manipulation of share price is being done. Look at the last two major share price news events. Right before options expiration. What are the odds of that?MP470 just missed with a 9.5 versus 10 response rate on a small sample. Is that reason to walk from a trial and what's left of a 25 million plus clinic and further research investment?
-